{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:24:17Z","timestamp":1774506257902,"version":"3.50.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Tremor is a hyperkinetic movement disorder most commonly encountered in essential tremor (ET) and Parkinson\u2019s disease (PD). The purpose of this review is to summarize molecular neuroimaging studies with major implications on pathophysiological and clinical features of tremor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Oscillatory brain activity responsible for tremor manifestation is thought to originate in a cerebello-thalamo-cortical network. Molecular neuroimaging has helped clarify metabolic aspects and neurotransmitter influences on the main tremor network. In ET, recent positron emission tomography (PET) studies are built on previous knowledge and highlighted the possibility of investigating metabolic brain changes after treatments, in the attempt to establish therapeutic biomarkers. In PD, molecular neuroimaging has advanced the knowledge of non-dopaminergic determinants of tremor, providing insights into serotonergic and noradrenergic contributions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Recent advances have greatly extended the knowledge of tremor pathophysiology and it is now necessary to translate such knowledge in more efficacious treatments for this symptom.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11910-021-01157-4","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T14:02:51Z","timestamp":1637762571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Molecular Neuroimaging of Tremor"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2995","authenticated-orcid":false,"given":"Jacopo","family":"Pasquini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-9406","authenticated-orcid":false,"given":"Roberto","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"1157_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33:75\u201387.","journal-title":"Mov Disord."},{"key":"1157_CR2","first-page":"1","volume":"9","author":"A Tarakad","year":"2019","unstructured":"Tarakad A, Jankovic J. Essential tremor and parkinson\u2019s disease: exploring the relationship. Tremor and Other Hyperkinetic Movements. 2019;9:1\u201310.","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"1157_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1054\/jocn.2001.1017","volume":"9","author":"JA Burne","year":"2002","unstructured":"Burne JA, Hayes MW, Fung VSC, Yiannikas C, Boljevac D. The contribution of tremor studies to diagnosis of Parkinsonian and essential tremor: a statistical evaluation. J Clin Neurosci. 2002;9:237\u201342.","journal-title":"J Clin Neurosci"},{"key":"1157_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11910-013-0378-8","volume":"13","author":"RC Helmich","year":"2013","unstructured":"Helmich RC, Toni I, Deuschl G, Bloem BR. The pathophysiology of essential tremor and Parkinson\u2019s tremor. Curr Neurol Neurosci Rep. 2013;13:378 (Springer US).","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1157_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/nmt.12.23","volume":"2","author":"AH Rajput","year":"2012","unstructured":"Rajput AH, Adler CH, Shill HA, Rajput A. Essential tremor is not a neurodegenerative disease. Neurodegener Dis Manag Future Medicine Ltd. 2012;2:259\u201368.","journal-title":"Neurodegener Dis Manag Future Medicine Ltd"},{"key":"1157_CR6","doi-asserted-by":"publisher","unstructured":"Louis ED, Faust PL. Essential tremor: The most common form of cerebellar degeneration? Cerebellum and Ataxias.\u00a02020;7:12.\u00a0https:\/\/doi.org\/10.1186\/s40673-020-00121-1","DOI":"10.1186\/s40673-020-00121-1"},{"key":"1157_CR7","doi-asserted-by":"publisher","unstructured":"Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol. Elsevier;\u00a010:148\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(10)70322-7.","DOI":"10.1016\/S1474-4422(10)70322-7"},{"key":"1157_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/0140-6736(90)92489-5","volume":"336","author":"JG Colebatch","year":"1990","unstructured":"Colebatch JG, Frackowiak RSJ, Brooks DJ, Colebatch JG, Findley LJ, Marsden CM. Preliminary report: activation of the cerebellum in essential tremor. Lancet. 1990;336:1028\u201330.","journal-title":"Lancet"},{"key":"1157_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.410340115","volume":"34","author":"IH Jenkins","year":"1993","unstructured":"Jenkins IH, Bain PG, Colebatch JG, Thompson PD, Findley LJ, Frackowiak RSJ, et al. A positron emission tomography study of essential tremor: Evidence for overactivity of cerebellar connections. Ann Neurol. 1993;34:82\u201390.","journal-title":"Ann Neurol"},{"key":"1157_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ana.410360413","volume":"36","author":"AJ Wills","year":"1994","unstructured":"Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomoraphic study. Ann Neurol. 1994;36:636\u201342.","journal-title":"Ann Neurol"},{"key":"1157_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archneur.1995.00540270095025","volume":"52","author":"AJ Wills","year":"1995","unstructured":"Wills AJ, Jenkins LH, Thompson PD, Findley LJ, Brooks DJ. A positron emission tomography study of cerebral activation associated with essential and writing tremor. Arch Neurol Arch Neurol. 1995;52:299\u2013305.","journal-title":"Arch Neurol Arch Neurol"},{"key":"1157_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.parkreldis.2011.01.012","volume":"17","author":"K Czarnecki","year":"2011","unstructured":"Czarnecki K, Jones DT, Burnett MS, Mullan B, Matsumoto JY. SPECT perfusion patterns distinguish psychogenic from essential tremor. Park Relat Disord Parkinsonism Relat Disord. 2011;17:328\u201332.","journal-title":"Park Relat Disord Parkinsonism Relat Disord"},{"key":"1157_CR13","first-page":"45","volume":"114","author":"M Hallett","year":"1993","unstructured":"Hallett M, Dubinsky RM. Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci J Neurol Sci. 1993;114:45\u20138.","journal-title":"J Neurol Sci J Neurol Sci"},{"key":"1157_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0284185114531414","volume":"56","author":"SW Ha","year":"2015","unstructured":"Ha SW, Yang YS, Song IU, Chung YA, Oh JK, Chung SW. Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor. Acta radiol. 2015;56:482\u20136.","journal-title":"Acta radiol"},{"key":"1157_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3348\/kjr.2015.16.5.967","volume":"16","author":"I-U Song","year":"2015","unstructured":"Song I-U, Ha S-W, Yang Y-S, Chung Y-A. Differences in regional glucose metabolism of the brain measured with F-18-FDG-PET in patients with essential tremor according to their response to beta-blockers. Korean J Radiol. 2015;16:967.","journal-title":"Korean J Radiol"},{"key":"1157_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Verger A, Witjas T, Carron R, Eusebio A, Boutin E, Azulay JP, et al. Metabolic\npositron emission tomography response to gamma knife of the ventral intermediate nucleus in essential tremor. Neurosurgery. 2019;84:E294\u2013303.\u00a0This study used FDG-PET to analyse brain metabolic characteristics in 42 ET patients before and after Vim thalamotomy. Dynamic changes in cerebral metabolism after surgery were found aftery surgery, indicating potential therapeutic biomarkers.","DOI":"10.1093\/neuros\/nyy340"},{"key":"1157_CR17","doi-asserted-by":"crossref","unstructured":"\u2022 Barath AS, Rusheen AE, Min HK, Lee J, Ross E, Shin S, et al. Brain metabolic changes with longitudinal transcutaneous afferent patterned stimulation in essential tremor subjects. Tremor and Other Hyperkinetic Movements. Center for Digital Research and Scholarship; 2020;10:1\u201310. This study used FDG-PET to characterise metabolic brain changes before and 90 days after the application of a novel treatment for essential tremor, transcutanous afferent patterned stimulation. FDG-PET revealed increased metabolism in the cerebellar hemisphere ipsilateral to the stimulation and hypometabolism contralaterally, and a moderate-strong correlation was found between the change in tremor severity and the change in FDG uptake in the hypermetabolic hemicerebellum.","DOI":"10.5334\/tohm.565"},{"key":"1157_CR18","doi-asserted-by":"publisher","unstructured":"Lin PT, Ross EK, Chidester P, Rosenbluth KH, Hamner SR, Wong SH, et al. Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial. Mov Disord.\u00a02018;33:1182\u20131183. https:\/\/doi.org\/10.1002\/mds.27350","DOI":"10.1002\/mds.27350"},{"key":"1157_CR19","first-page":"1554","volume":"42","author":"DJ Brooks","year":"1992","unstructured":"Brooks DJ, Playford ED, Ibanez V, Sawle GV, Thompson PD, Findley CW, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology Wolters Kluwer Health, Inc on behalf of the American Academy of Neurology. 1992;42:1554\u201360.","journal-title":"Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology"},{"key":"1157_CR20","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1212\/WNL.55.10.1540","volume":"55","author":"Parkinson Study Group","year":"2000","unstructured":"Parkinson Study Group. A multicenter assessment of dopamine transporter imaging with DOPASCAN\/SPECT in parkinsonism. Neurology. 2000;55:1540\u20137.","journal-title":"Neurology"},{"key":"1157_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000;15:503\u201310.","journal-title":"Mov Disord"},{"key":"1157_CR22","doi-asserted-by":"publisher","unstructured":"Antonini A, Moresco RM, Gobbo C, De Notaris R, Panzacchi A, Barone P, et al. The status of dopamine nerve terminals in Parkinson\u2019s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol Sci. 2001;22:47\u201348.\u00a0https:\/\/doi.org\/10.1007\/s100720170040.","DOI":"10.1007\/s100720170040"},{"key":"1157_CR23","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","volume":"39","author":"D Di Giuda","year":"2012","unstructured":"Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, et al. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2012;39:1937\u201348.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1157_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/mds.22870","volume":"25","author":"IU Isaias","year":"2010","unstructured":"Isaias IU, Marotta G, Hirano S, Canesi M, Benti R, Righini A, et al. Imaging essential tremor. Mov Disord. 2010;25:679\u201386.","journal-title":"Mov Disord"},{"key":"1157_CR25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/mds.23179","volume":"25","author":"F Roselli","year":"2010","unstructured":"Roselli F, Pisciotta NM, Pennelli M, Aniello MS, Gigante A, De Caro MF, et al. Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study. Mov Disord Mov Disord. 2010;25:1853\u20139.","journal-title":"Mov Disord Mov Disord"},{"key":"1157_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s007020050124","volume":"105","author":"S Asenbaum","year":"1998","unstructured":"Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Br\u00fccke T. [123I]\u03b2-CIT and SPECT in essential tremor and Parkinson\u2019s disease. J Neural Transm. 1998;105:1213\u201328.","journal-title":"J Neural Transm"},{"key":"1157_CR27","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/WNL.52.7.1422","volume":"52","author":"MS Lee","year":"1999","unstructured":"Lee MS, Kim YD, Im JH, Kim HJ, Rinne JO, Bhatia KP. 123I-IPT brain SPECT study in essential tremor and Parkinson\u2019s disease. Neurology. 1999;52:1422\u20136.","journal-title":"Neurology"},{"key":"1157_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.parkreldis.2004.03.004","volume":"10","author":"M Schwartz","year":"2004","unstructured":"Schwartz M, Groshar D, Inzelberg R, Hocherman S. Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson\u2019s disease. Park Relat Disord Elsevier. 2004;10:385\u20139.","journal-title":"Park Relat Disord Elsevier"},{"key":"1157_CR29","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/mds.22259","volume":"23","author":"R Ceravolo","year":"2008","unstructured":"Ceravolo R, Antonini A, Volterrani D, Rossi C, Kiferle L, Frosini D, et al. Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study. Mov Disord. 2008;23:2049\u201354.","journal-title":"Mov Disord"},{"key":"1157_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1468-1331.2012.03875.x","volume":"20","author":"M De Verdal","year":"2013","unstructured":"De Verdal M, Renard D, Collombier L, Boudousq V, Kotzki PO, Labauge P, et al. I123-FP-CIT single-photon emission tomography in patients with long-standing mixed tremor. Eur J Neurol. 2013;20:382\u20138.","journal-title":"Eur J Neurol"},{"key":"1157_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2011.08.025","volume":"18","author":"F Coria","year":"2012","unstructured":"Coria F, Gimenez-Garcia M, Samaranch L, Mora FJ, Sampol-Bas C, Pastor P. Nigrostriatal dopaminergic function in subjects with isolated action tremor. Park Relat Disord Elsevier Ltd. 2012;18:49\u201353.","journal-title":"Park Relat Disord Elsevier Ltd"},{"key":"1157_CR32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00702-015-1419-z","volume":"122","author":"O Waln","year":"2015","unstructured":"Waln O, Wu Y, Perlman R, Wendt J, Van AK, Jankovic J. Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm Springer Vienna. 2015;122:1515\u201321.","journal-title":"J Neural Transm Springer Vienna"},{"key":"1157_CR33","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/mds.22771","volume":"24","author":"F Novellino","year":"2009","unstructured":"Novellino F, Arabia G, Bagnato A, Cascini GL, Salsone M, Nicoletti G, et al. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov Disord. 2009;24:2242\u20138.","journal-title":"Mov Disord"},{"key":"1157_CR34","first-page":"3297","volume":"130","author":"ED Louis","year":"2007","unstructured":"Louis ED, Faust PL, Vonsattel JPG, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain Oxford University Press. 2007;130:3297\u2013307.","journal-title":"Brain Oxford University Press"},{"key":"1157_CR35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2967\/jnumed.109.074120","volume":"51","author":"H Boecker","year":"2010","unstructured":"Boecker H, Weindl A, Brooks DJ, Ceballos-Baumann AO, Liedtke C, Miederer M, et al. GABAergic dysfunction in essential tremor: an 11c-flumazenil PET study. J Nucl Med J Nucl Med. 2010;51:1030\u20135.","journal-title":"J Nucl Med J Nucl Med"},{"key":"1157_CR36","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.parkreldis.2012.04.024","volume":"18","author":"A Gironell","year":"2012","unstructured":"Gironell A, Figueiras FP, Pagonabarraga J, Herance JR, Pascual-Sedano B, Trampal C, et al. Gaba and serotonin molecular neuroimaging in essential tremor: a clinical correlation study. Park Relat Disord Elsevier Ltd. 2012;18:876\u201380.","journal-title":"Park Relat Disord Elsevier Ltd"},{"key":"1157_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12311-017-0891-4","volume":"17","author":"ED Louis","year":"2018","unstructured":"Louis ED, Hernandez N, Dyke JP, Ma RE, Dydak U. In vivo dentate nucleus gamma-aminobutyric acid concentration in essential tremor vs. controls. Cerebellum. 2018;17:165\u201372 (Springer New York LLC).","journal-title":"Cerebellum"},{"key":"1157_CR38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/mds.23179","volume":"25","author":"F Roselli","year":"2010","unstructured":"Roselli F, Pisciotta NM, Pennelli M, Aniello MS, Gigante A, De Caro MF, et al. Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study. Mov Disord. 2010;25:1853\u20139.","journal-title":"Mov Disord"},{"key":"1157_CR39","doi-asserted-by":"publisher","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340.","DOI":"10.1002\/mds.22340"},{"key":"1157_CR40","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/brain\/aws023","volume":"135","author":"RC Helmich","year":"2012","unstructured":"Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135:3206\u201326.","journal-title":"Brain"},{"key":"1157_CR41","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1212\/WNL.0000000000005215","volume":"90","author":"MF Dirkx","year":"2018","unstructured":"Dirkx MF, Zach H, Bloem BR, Hallett M, Helmich RC. The nature of postural tremor in Parkinson disease. Neurology. 2018;90:e1095\u2013103.","journal-title":"Neurology"},{"key":"1157_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/ene.13619","volume":"25","author":"D Belvisi","year":"2018","unstructured":"Belvisi D, Conte A, Cutrona C, Costanzo M, Ferrazzano G, Fabbrini G, et al. Re-emergent tremor in Parkinson\u2019s disease: the effect of dopaminergic treatment. Eur J Neurol. 2018;25:799\u2013804.","journal-title":"Eur J Neurol"},{"key":"1157_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0006-8993(92)90872-7","volume":"584","author":"F Parker","year":"1992","unstructured":"Parker F, Tzourio N, Blond S, Petit H, Mazoyer B. Evidence for a common network of brain structures involved in Parkinsonian tremor and voluntary repetitive movement. Brain Res Elsevier. 1992;584:11\u20137.","journal-title":"Brain Res Elsevier"},{"key":"1157_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/brain\/116.1.267","volume":"116","author":"MP Deiber","year":"1993","unstructured":"Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, et al. Thalamic stimulation and suppression of parkinsonian tremor: evidence of a cerebellar deactivation using positron emission tomography. Brain Brain. 1993;116:267\u201379.","journal-title":"Brain Brain"},{"key":"1157_CR45","doi-asserted-by":"crossref","unstructured":"Davis KD, Taub E, Houle S, Lang AE, Dostrovsky JO, Tasker RR, Lozano AM. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med. 1997;3(6):671\u20134. https:\/\/doi.org\/10.1038\/nm0697-671.","DOI":"10.1038\/nm0697-671"},{"key":"1157_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of Parkinsonism. J Cereb Blood Flow Metab. 1994;14:783\u2013801 (Nature Publishing Group).","journal-title":"J Cereb Blood Flow Metab."},{"key":"1157_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","volume":"27","author":"Y Ma","year":"2007","unstructured":"Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson\u2019s disease: test-retest reproducibility. J Cereb Blood Flow Metab. 2007;27:597\u2013605 (NIH Public Access).","journal-title":"J Cereb Blood Flow Metab"},{"key":"1157_CR48","doi-asserted-by":"crossref","unstructured":"Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson\u2019s disease: a metabolic network approach. Lancet Neurol. 2007;6(10):926\u201332. https:\/\/doi.org\/10.1016\/S1474-4422(07)70245-4.","DOI":"10.1016\/S1474-4422(07)70245-4"},{"key":"1157_CR49","first-page":"803","volume":"51","author":"A Antonini","year":"1998","unstructured":"Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. The metabolic anatomy of tremor in Parkinson\u2019s disease. Neurology Lippincott Williams and Wilkins. 1998;51:803\u201310.","journal-title":"Neurology Lippincott Williams and Wilkins"},{"key":"1157_CR50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.09.028","volume":"54","author":"H Mure","year":"2011","unstructured":"Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, et al. Parkinson\u2019s disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage Neuroimage. 2011;54:1244\u201353.","journal-title":"Neuroimage Neuroimage"},{"key":"1157_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0096629","volume":"9","author":"C Eggers","year":"2014","unstructured":"Eggers C, Schwartz F, Pedrosa DJ, Kracht L, Timmermann L. Parkinson\u2019s disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum. PLoS ONE. 2014;9:1\u20137.","journal-title":"PLoS ONE"},{"key":"1157_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mds.870050304","volume":"5","author":"D Eidelberg","year":"1990","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, et al. The metabolic anatomy of Parkinson\u2019s disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Mov Disord. 1990;5:203\u201313 (John Wiley & Sons, Ltd).","journal-title":"Mov Disord."},{"key":"1157_CR53","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marchek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, et al. Decreased single-photon emission computed tomographic {123I}?-CIT striatal uptake correlates with symptom severity in Parkinson\u2019s disease. Ann Neurol. 1995;38:589\u201398.","journal-title":"Ann Neurol"},{"key":"1157_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/archneur.1995.00540360061017","volume":"52","author":"A Antonini","year":"1995","unstructured":"Antonini A, Vontobel P, Psylla M, G\u00fcnther I, Maguire PR, Missimer J, et al. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson\u2019s disease. Arch Neurol Arch Neurol. 1995;52:1183\u201390.","journal-title":"Arch Neurol Arch Neurol"},{"key":"1157_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.410410111","volume":"41","author":"FJG Vingerhoets","year":"1997","unstructured":"Vingerhoets FJG, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson\u2019s disease best reflects the nigrostriatal lesion? Ann Neurol. 1997;41:58\u201364.","journal-title":"Ann Neurol"},{"key":"1157_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0022-510X(95)00316-T","volume":"136","author":"M Otsuka","year":"1996","unstructured":"Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Yoshida T, et al. Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson\u2019s disease: correlations with the three main symptoms. J Neurol Sci Elsevier. 1996;136:169\u201373.","journal-title":"J Neurol Sci Elsevier"},{"key":"1157_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-7091-6842-4_2","volume":"50","author":"T Br\u00fccke","year":"1997","unstructured":"Br\u00fccke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, W\u00f6ber C, et al. Measurement of the dopaminergic degeneration in Parkinson\u2019s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl. 1997;50:9\u201324.","journal-title":"J Neural Transm Suppl"},{"key":"1157_CR58","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jnnp.67.6.737","volume":"67","author":"JO Rinne","year":"1999","unstructured":"Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P, Solin O. Usefulness of a dopamine transporter PET ligand [18F]\u03b2-CFT in assessing disability in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:737\u201341 (BMJ Publishing Group).","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1157_CR59","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson\u2019s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692\u20138.","journal-title":"Mov Disord"},{"key":"1157_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/1531-8257(200101)16:1<124::AID-MDS1007>3.0.CO;2-R","volume":"16","author":"TH Haapaniemi","year":"2001","unstructured":"Haapaniemi TH, Ahonen A, Torniainen P, Sotaniemi KA, Myllyla VV. [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord. 2001;16:124\u201330.","journal-title":"Mov Disord"},{"key":"1157_CR61","doi-asserted-by":"crossref","unstructured":"Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? Mov. Disord. Mov Disord; 2003.","DOI":"10.1002\/mds.10579"},{"key":"1157_CR62","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mds.1205","volume":"16","author":"A Winogrodzka","year":"2001","unstructured":"Winogrodzka A, Wagenaar RC, Bergmans P, Vellinga A, Booij J, van Royen EA, et al. Rigidity decreases resting tremor intensity in Parkinson\u2019s disease: a [123I]\u03b2-CIT SPECT study in early, nonmedicated patients. Mov Disord. 2001;16:1033\u201340.","journal-title":"Mov Disord"},{"key":"1157_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2021.03.003","volume":"85","author":"AF Fois","year":"2021","unstructured":"Fois AF, Chang FC, Barnett R, London K, Mahant N, Ha A, et al. Rest tremor correlates with reduced contralateral striatal dopamine transporter binding in Parkinson\u2019s disease. Park Relat Disord Elsevier Ltd. 2021;85:102\u20138.","journal-title":"Park Relat Disord Elsevier Ltd"},{"key":"1157_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","volume":"114","author":"J Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Samnick S, Jost W, M\u00f6llers M-O, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease. J neural Transm (Vienna, Austria). 2007;114:331\u20135.","journal-title":"J neural Transm (Vienna, Austria)"},{"key":"1157_CR65","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1468-1331.2009.02898.x","volume":"17","author":"C Rossi","year":"2010","unstructured":"Rossi C, Frosini D, Volterrani D, De Feo P, Unti E, Nicoletti V, et al. Differences in nigro-striatal impairment in clinical variants of early Parkinson\u2019s disease: Evidence from a FP-CIT SPECT study. Eur J Neurol. 2010;17:626\u201330.","journal-title":"Eur J Neurol"},{"key":"1157_CR66","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mds.23468","volume":"26","author":"C Eggers","year":"2011","unstructured":"Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L. Akinetic-rigid and tremor-dominant Parkinson\u2019s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord. 2011;26:416\u201323 (John Wiley & Sons, Ltd).","journal-title":"Mov Disord."},{"key":"1157_CR67","doi-asserted-by":"crossref","unstructured":"Jellinger K. Post mortem studies in Parkinson\u2019s disease - is it possible to detect brain areas for specific symptoms. J Neural Transm Suppl. Springer Wien; 1999; 1\u201329.","DOI":"10.1007\/978-3-7091-6360-3_1"},{"key":"1157_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.22361","volume":"69","author":"RC Helmich","year":"2011","unstructured":"Helmich RC, Janssen MJR, Oyen WJG, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol. 2011;69:269\u201381.","journal-title":"Ann Neurol"},{"key":"1157_CR69","first-page":"601","volume":"60","author":"M Doder","year":"2003","unstructured":"Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ. Tremor in Parkinson\u2019s disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology Lippincott Williams and Wilkins. 2003;60:601\u20135.","journal-title":"Neurology Lippincott Williams and Wilkins"},{"key":"1157_CR70","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain. 2015;138:2964\u201373.","journal-title":"Brain"},{"key":"1157_CR71","doi-asserted-by":"crossref","unstructured":"\u2022\u00a0Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, et al. Progression of\ntremor in early stages of Parkinson\u2019s disease: a clinical and neuroimaging study. Brain. 2018;141:811\u201321. This study characterises the relationship between the relative contributions of the dopaminergic and serotonergic systems in the clinical manifestation of PD rest tremor and its response to levodopa.","DOI":"10.1093\/brain\/awx376"},{"key":"1157_CR72","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/WNL.0b013e318292a31d","volume":"80","author":"C Loane","year":"2013","unstructured":"Loane C, Wu K, Bain P, David J, Piccini P, Politis M. Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD. Neurology. 2013;80:1850\u20135.","journal-title":"Neurology"},{"key":"1157_CR73","first-page":"1498","volume":"143","author":"MF Dirkx","year":"2020","unstructured":"Dirkx MF, Zach H, van Nuland AJ, Bloem BR, Toni I, Helmich RC. Cognitive load amplifies Parkinson\u2019s tremor through excitatory network influences onto the thalamus. Brain Oxford University Press. 2020;143:1498\u2013511.","journal-title":"Brain Oxford University Press"},{"key":"1157_CR74","first-page":"179","volume":"5","author":"IU Isaias","year":"2011","unstructured":"Isaias IU, Marzegan A, Pezzoli G, Marotta G, Canesi M, Biella GEM, et al. A role for locus coeruleus in Parkinson tremor. Front Hum Neurosci. 2011;5:179.","journal-title":"Front Hum Neurosci"},{"key":"1157_CR75","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.117.190975","volume":"59","author":"A Nahimi","year":"2018","unstructured":"Nahimi A, Sommerauer M, Kinnerup MB, \u00d8stergaard K, Wintherdahl M, Jacobsen J, et al. Noradrenergic deficits in Parkinson disease imaged with 11C-MeNER. J Nucl Med. 2018;59:659\u201364.","journal-title":"J Nucl Med"},{"key":"1157_CR76","doi-asserted-by":"crossref","unstructured":"\u2022\u00a0Kinnerup MB, Sommerauer M, Damholdt MF, Schaldemose JL, Ismail R, Terkelsen AJ, et al. Preserved noradrenergic function in Parkinson\u2019s disease patients with rest tremor. Neurobiol Dis. 2021;152:105295 This study used a novel PET tracer for the noradrenergic transporter (NET) in PD, 11C-MeNER, to highlight that tremulous patients have preserved locus coeruelus NET while denervated median raphe. Severity of median raphe NET denervation is associated with tremor severity. Elsevier Inc.","DOI":"10.1016\/j.nbd.2021.105295"},{"key":"1157_CR77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mds.870050115","volume":"5","author":"J Rivest","year":"1990","unstructured":"Rivest J, Marsden CD. Trunk and head tremor as isolated manifestations of dystonia. Mov Disord Mov Disord. 1990;5:60\u20135.","journal-title":"Mov Disord Mov Disord"},{"key":"1157_CR78","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/mds.23289","volume":"26","author":"NP Quinn","year":"2011","unstructured":"Quinn NP, Schneider SA, Schwingenschuh P, Bhatia KP. Tremor-some controversial aspects. Mov Disord Mov Disord. 2011;26:18\u201323.","journal-title":"Mov Disord Mov Disord"},{"key":"1157_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000351698","volume":"41","author":"ED Louis","year":"2013","unstructured":"Louis ED. When do essential tremor patients develop head tremor? influences of age and duration and evidence of a biological clock. Neuroepidemiology Neuroepidemiology. 2013;41:110\u20135.","journal-title":"Neuroepidemiology Neuroepidemiology"},{"key":"1157_CR80","doi-asserted-by":"crossref","unstructured":"\u2022\u00a0Ferrazzano G, Frantellizzi V, De Bartolo MI, De Feo MS, Conte A, Fabbrini G, et al. Isolated head tremor: a DAT-SPECT and somatosensory temporal discrimination study. Park Relat Disord. Elsevier Ltd; 2020;81:56\u20139. This study highlights isolated head tremor characteristics that suggest that this entity is a form of dystonia with presevered nigrostriatal DaT availability.","DOI":"10.1016\/j.parkreldis.2020.10.015"},{"key":"1157_CR81","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5334\/tohm.267","volume":"5","author":"M Karimi","year":"2015","unstructured":"Karimi M, Perlmutter JS. The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging. Tremor and Other Hyperkinetic Movements. 2015;5:280.","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"1157_CR82","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.parkreldis.2021.05.023","volume":"87","author":"L Williams","year":"2021","unstructured":"Williams L, Butler JS, O\u2019Riordan S, Skeehan S, Collins C, Hutchinson M. Response to \u201cisolated head tremor: a DAT SPECT and somatosensory temporal discrimination study.\u201d Parkinsonism Relat Disord Elsevier BV. 2021;87:166\u20137.","journal-title":"Parkinsonism Relat Disord Elsevier BV"},{"key":"1157_CR83","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1212\/WNL.0000000000002440","volume":"86","author":"GB Raina","year":"2016","unstructured":"Raina GB, Cersosimo MG, Folgar SS, Giugni JC, Calandra C, Paviolo JP, et al. Holmes tremor. Neurology. 2016;86:931\u20138.","journal-title":"Neurology"},{"key":"1157_CR84","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ana.25618","volume":"86","author":"J Joutsa","year":"2019","unstructured":"Joutsa J, Shih LC, Fox MD. Mapping Holmes tremor circuit using the human brain connectome. Ann Neurol. 2019;86:812\u201320 (John Wiley and Sons Inc.).","journal-title":"Ann Neurol."},{"key":"1157_CR85","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/acn3.51143","volume":"7","author":"F Nieuwhof","year":"2020","unstructured":"Nieuwhof F, de Bie RMA, Praamstra P, van den Munckhof P, Helmich RC. The cerebral tremor circuit in a patient with Holmes tremor. Ann Clin Transl Neurol. 2020;7:1453\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"1157_CR86","first-page":"360","volume":"122","author":"A Gajos","year":"2010","unstructured":"Gajos A, Bogucki A, Schinwelski M, So\u0142tan W, Rudzi\u0144ska M, Budrewicz S, et al. The clinical and neuroimaging studies in Holmes tremor. Acta Neurol Scand. 2010;122:360\u20136.","journal-title":"Acta Neurol Scand"},{"key":"1157_CR87","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00702-017-1780-1","volume":"124","author":"A Gajos","year":"2017","unstructured":"Gajos A, Budrewicz S, Koszewicz M, Bie\u0144kiewicz M, D\u0105browski J, Ku\u015bmierek J, et al. Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study. J Neural Transm. 2017;124:1389\u201393.","journal-title":"J Neural Transm"},{"key":"1157_CR88","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.nbd.2021.105295","volume":"152","author":"MB Kinnerup","year":"2021","unstructured":"Kinnerup MB, Sommerauer M, Damholdt MF, Schaldemose JL, Ismail R, Terkelsen AJ, et al. Preserved noradrenergic function in Parkinson\u2019s disease patients with rest tremor. Neurobiol Dis. 2021;152:105295 (Elsevier Inc.).","journal-title":"Neurobiol Dis."},{"key":"1157_CR89","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1006\/nimg.2002.1245","volume":"17","author":"C Lozza","year":"2002","unstructured":"Lozza C, Mari\u00e9 R-M, Baron J-C. The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson\u2019s disease. Neuroimage Elsevier BV. 2002;17:688\u201399.","journal-title":"Neuroimage Elsevier BV"},{"key":"1157_CR90","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00702-007-0015-2","volume":"115","author":"V Caretti","year":"2008","unstructured":"Caretti V, Stoffers D, Winogrodzka A, Isaias I-U, Costantino G, Pezzoli G, et al. Loss of thalamic serotonin transporters in early drug-na\u00efve Parkinson\u2019s disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study. J Neural Transm. 2008;115:721\u20139.","journal-title":"J Neural Transm."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01157-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T16:49:12Z","timestamp":1675961352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01157-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"17 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacopo Pasquini and Roberto Ceravolo declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"74"}}